| scholarly article | Q13442814 |
| P2093 | author name string | Diane T Finegood | |
| Mark Lipsett | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hyperglycemia | Q271993 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1834-1841 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | beta-cell neogenesis during prolonged hyperglycemia in rats | |
| P478 | volume | 51 |
| Q45113390 | A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. |
| Q40242890 | A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones |
| Q34043378 | Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats |
| Q37037141 | Activation of phosphatidylinositol-3 kinase regulates pancreatic duodenal homeobox-1 in duct cells during pancreatic regeneration |
| Q29614736 | Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation |
| Q33286067 | All beta cells contribute equally to islet growth and maintenance |
| Q36766176 | Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough |
| Q33525054 | Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass |
| Q44064773 | Cellular origins of adult human islet in vitro dedifferentiation |
| Q36626927 | Cellular pathways to beta-cell replacement |
| Q46052435 | Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus |
| Q78419821 | Current literature in diabetes |
| Q35651511 | Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications |
| Q27020942 | Development, growth and maintenance of β-cell mass: models are also part of the story |
| Q37797970 | Diabetes as a disease of endoplasmic reticulum stress |
| Q42468776 | Differentiated mesenchymal stem cells ameliorate cardiovascular complications in diabetic rats |
| Q36076469 | Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells |
| Q30489415 | Dynamics of beta-cell turnover: evidence for beta-cell turnover and regeneration from sources of beta-cells other than beta-cell replication in the HIP rat |
| Q38007405 | Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development |
| Q28581365 | Enhanced beta-cell mass without increased proliferation following chronic mild glucose infusion |
| Q51802342 | Evidence for the homeostatic regulation of induced beta cell mass expansion. |
| Q44675508 | Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas |
| Q46794499 | Extrinsic factors promoting in vitro differentiation of insulin-secreting cells from human adipose tissue-derived mesenchymal stem cells |
| Q35774014 | FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2). |
| Q36328926 | Facilitating physiologic self-regeneration: a step beyond islet cell replacement |
| Q64896146 | Functional adenosine triphosphate-sensitive potassium channel is required in high-carbohydrate diet-induced increase in β-cell mass. |
| Q46924375 | Generation of islet-like hormone-producing cells in vitro from adult human pancreas |
| Q53117314 | Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat. |
| Q34066982 | Glucose infusion in mice: a new model to induce beta-cell replication |
| Q42487818 | Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets |
| Q37283982 | Growth factor control of pancreatic islet regeneration and function |
| Q38800106 | Impact of islet architecture on β-cell heterogeneity, plasticity and function |
| Q39028265 | Implantation of bFGF-treated islet progenitor cells ameliorates streptozotocin-induced diabetes in rats. |
| Q24300607 | In the search of potential human islet stem cells: is tetranectin showing us the way? |
| Q34967985 | In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion |
| Q36279958 | In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts |
| Q35131698 | Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation |
| Q50966641 | Increased susceptibility to streptozotocin and impeded regeneration capacity of beta-cells in adult offspring of malnourished rats. |
| Q34016151 | Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes |
| Q45045299 | Metabolic adaptations to chronic glucose infusion in rats |
| Q33933004 | Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) gene |
| Q34490166 | Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate |
| Q37278665 | Neurogenin 3 is regulated by neurotrophic tyrosine kinase receptor type 2 (TRKB) signaling in the adult human exocrine pancreas |
| Q36905220 | New sources of pancreatic beta cells |
| Q33983765 | Non-β-cell progenitors of β-cells in pregnant mice. |
| Q36570275 | Pancreatic endocrine and exocrine cell ontogeny from renal capsule transplanted embryonic stem cells in streptozocin-injured mice |
| Q26752571 | Pancreatic β Cell Mass Death |
| Q37832150 | Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes |
| Q33983473 | Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice |
| Q36995389 | Progress and challenges for treating Type 1 diabetes |
| Q37407901 | Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein |
| Q42460121 | Quantification of the relationship between glycemia and beta-cell mass adaptation in vivo |
| Q33566004 | Regeneration of the pancreatic beta cell |
| Q36267776 | Regulation of pancreatic beta-cell mass |
| Q91980290 | Short-Term High-Starch, Low-Protein Diet Induces Reversible Increase in β-cell Mass Independent of Body Weight Gain in Mice |
| Q33647542 | Slow and steady is the key to beta-cell replication |
| Q44440569 | Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic β-Cell Mass in Vivo in Adult Rats |
| Q37369660 | Stem Cells in the Treatment of Insulin-Dependent Diabetes Mellitus |
| Q35622965 | Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes |
| Q35832775 | Stem-cell therapy for diabetes mellitus. |
| Q53593077 | Streptozotocin-induced partial beta cell depletion in nude mice without hyperglycaemia induces pancreatic morphogenesis in transplanted embryonic stem cells. |
| Q46736684 | Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? |
| Q31132382 | TNF-like weak inducer of apoptosis (TWEAK) promotes beta cell neogenesis from pancreatic ductal epithelium in adult mice |
| Q57692348 | Testing the plasticity of insulin secretion and β-cell functionin vivo: responses to chronic hyperglycaemia in the sheep |
| Q38012149 | The potential benefit of non-purified islets preparations for islet transplantation |
| Q36426351 | The potential for stem cell therapy in diabetes. |
| Q37377618 | Therapeutic Strategies to Increase Human β-Cell Growth and Proliferation by Regulating mTOR and GSK-3/β-Catenin Pathways |
| Q34699211 | Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms |
| Q35416441 | Transgenic overexpression of the transcription factor Nkx6.1 in β-cells of mice does not increase β-cell proliferation, β-cell mass, or improve glucose clearance. |
| Q81517210 | Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats |
| Q38134109 | β-Cell differentiation and regeneration in type 1 diabetes |
Search more.